These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7368019)

  • 1. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets.
    Fletcher S; Summers RS
    S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.
    Shaw TR; Raymond K; Howard MR; Hamer J
    Br Med J; 1973 Dec; 4(5895):763-6. PubMed ID: 4758573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-equivalence of digoxin tablets in the U.K. and its clinical implications.
    Shaw TR
    Postgrad Med J; 1974 Nov; 50 Suppl 6():24-9. PubMed ID: 4459884
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the biologic availability of digoxin in man.
    Fleckenstein L; Kroening B; Weintraub M
    Clin Pharmacol Ther; 1974 Sep; 16(3):435-43. PubMed ID: 4606249
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognition of variable bioavailability as an international problem: a review of the earlier studies.
    Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882
    [No Abstract]   [Full Text] [Related]  

  • 10. Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation.
    Sun M; Sun J; He S; Wang Y; Sun Y; Liu X; He Z
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1099-106. PubMed ID: 22188158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
    Babalola CP; Oladimeji FA; Femi-Oyewo MN
    Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dissolution rate of digoxin tablets on the U.K. market: the scale of the problem.
    Cowan DA; Beckett AH
    Postgrad Med J; 1974 Nov; 50 Suppl 6():52-5. PubMed ID: 4459889
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug release in vitro from digoxin formulations with high bioavailability (author's transl)].
    Asmussen B; Heinz N
    Arzneimittelforschung; 1980; 30(12):2168-72. PubMed ID: 7194080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissolution properties of digoxin tablets marketed in the Republic of Ireland.
    Corrigan OI; Timoney RF
    Ir Med J; 1976 Feb; 69(3):60. PubMed ID: 1025046
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets.
    Johnson BF; Greer H; McCrerie JA; Bye C; Fowle AS
    Postgrad Med J; 1974 Nov; 50 Suppl 6():48-52. PubMed ID: 4617868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardioactive glycosides as a biopharmaceutical problem].
    Frömming KH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():29-33. PubMed ID: 611966
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.